Jessica Nickrand, PhD

home / authors / jessica-nickrand-phd

Director of programs at the Child Neurology Foundation.

Articles

Insights From the Child Neurology Foundation: Enhancing Pediatric Epilepsy Care Through Holistic Collaboration

Jessica Nickrand, PhD;Allyson Eyermann;Isabella Ciccone, MPH

January 24th 2025

Jessica Nickrand, PhD, and Allyson Eyermann from the Child Neurology Foundation emphasized the importance of multidisciplinary collaboration for children with epilepsy and their families.

Transforming Neurological Care for Children Through Education, Support, and Collaboration: Jessica Nickrand, PhD; Allyson Eyermann

Jessica Nickrand, PhD;Allyson Eyermann;Isabella Ciccone, MPH

December 18th 2024

A duo from Child Neurology Foundation discussed advancing care, providing education for all stakeholders, and offering direct support to families, clinicians, and caregivers navigating neurological conditions for pediatric patients. [WATCH TIME: 5 minutes]

Insights From Child Neurology Foundation on Advancing Holistic Epilepsy Care: Jessica Nickrand, PhD; Allyson Eyermann

Jessica Nickrand, PhD;Allyson Eyermann;Isabella Ciccone, MPH

December 16th 2024

A duo from the Child Neurology Foundation discussed multidisciplinary collaboration, innovations in epilepsy care, and the importance of holistic, family-centric approaches to improving patient outcomes at AES 2024. [WATCH TIME: 5 minutes]

Latest Updated Articles

Published: March 27th 2025 | Updated: March 28th 2025

FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome

Published: March 4th 2025 | Updated: March 19th 2025

BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts

Published: January 30th 2025 | Updated: February 21st 2025

FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management

Published: February 15th 2025 | Updated: February 18th 2025

Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS

Published: February 4th 2025 | Updated: February 6th 2025

FDA Approves Apomorphine Infusion Device SPN-830 as New Parkinson Treatment

Published: January 30th 2025 | Updated: February 4th 2025

FDA Approves Axsome Therapeutics’ AXS-07 for Migraine Treatment